IBDEI1TY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30637,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,30637,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,30638,0)
 ;;=D86.1^^135^1382^47
 ;;^UTILITY(U,$J,358.3,30638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30638,1,3,0)
 ;;=3^Sarcoidosis of Lymph nodes
 ;;^UTILITY(U,$J,358.3,30638,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,30638,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,30639,0)
 ;;=D86.2^^135^1382^46
 ;;^UTILITY(U,$J,358.3,30639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30639,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,30639,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,30639,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,30640,0)
 ;;=D86.89^^135^1382^48
 ;;^UTILITY(U,$J,358.3,30640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30640,1,3,0)
 ;;=3^Sarcoidosis of Other Sites
 ;;^UTILITY(U,$J,358.3,30640,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,30640,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,30641,0)
 ;;=D86.9^^135^1382^51
 ;;^UTILITY(U,$J,358.3,30641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30641,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,30641,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,30641,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,30642,0)
 ;;=D86.86^^135^1382^39
 ;;^UTILITY(U,$J,358.3,30642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30642,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,30642,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,30642,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,30643,0)
 ;;=D86.87^^135^1382^43
 ;;^UTILITY(U,$J,358.3,30643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30643,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,30643,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,30643,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,30644,0)
 ;;=D86.3^^135^1382^49
 ;;^UTILITY(U,$J,358.3,30644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30644,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,30644,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,30644,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,30645,0)
 ;;=D86.81^^135^1382^41
 ;;^UTILITY(U,$J,358.3,30645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30645,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,30645,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,30645,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,30646,0)
 ;;=D86.82^^135^1382^50
 ;;^UTILITY(U,$J,358.3,30646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30646,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,30646,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,30646,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,30647,0)
 ;;=D86.84^^135^1382^44
 ;;^UTILITY(U,$J,358.3,30647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30647,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,30647,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,30647,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,30648,0)
 ;;=D86.85^^135^1382^42
 ;;^UTILITY(U,$J,358.3,30648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30648,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,30648,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,30648,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,30649,0)
 ;;=D86.83^^135^1382^40
 ;;^UTILITY(U,$J,358.3,30649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30649,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,30649,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,30649,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,30650,0)
 ;;=D84.1^^135^1382^16
 ;;^UTILITY(U,$J,358.3,30650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30650,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,30650,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,30650,2)
 ;;=^5002439
